USD 30.98
(-0.03%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 468.3 Million USD | -0.77% |
2022 | 471.93 Million USD | -1.81% |
2021 | 480.65 Million USD | 23.95% |
2020 | 387.78 Million USD | 38.63% |
2019 | 279.72 Million USD | 149.78% |
2018 | 111.98 Million USD | 531.88% |
2017 | 17.72 Million USD | -36.51% |
2016 | 27.91 Million USD | -14.38% |
2015 | 32.6 Million USD | 117.48% |
2014 | 14.99 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 460.58 Million USD | -0.85% |
2024 Q1 | 464.52 Million USD | -0.81% |
2023 Q4 | 468.3 Million USD | 1.02% |
2023 Q1 | 468.68 Million USD | -0.69% |
2023 Q2 | 465.73 Million USD | -0.63% |
2023 Q3 | 463.59 Million USD | -0.46% |
2023 FY | 468.3 Million USD | -0.77% |
2022 Q4 | 471.93 Million USD | -0.61% |
2022 FY | 471.93 Million USD | -1.81% |
2022 Q1 | 503.86 Million USD | 4.83% |
2022 Q2 | 482.77 Million USD | -4.19% |
2022 Q3 | 474.84 Million USD | -1.64% |
2021 FY | 480.65 Million USD | 23.95% |
2021 Q3 | 470.02 Million USD | -3.55% |
2021 Q4 | 480.65 Million USD | 2.26% |
2021 Q2 | 487.31 Million USD | 2.86% |
2021 Q1 | 473.78 Million USD | 22.18% |
2020 Q1 | 353.55 Million USD | 26.39% |
2020 Q4 | 387.78 Million USD | 0.33% |
2020 Q3 | 386.52 Million USD | 0.46% |
2020 Q2 | 384.75 Million USD | 8.83% |
2020 FY | 387.78 Million USD | 38.63% |
2019 Q4 | 279.72 Million USD | -0.96% |
2019 FY | 279.72 Million USD | 149.78% |
2019 Q1 | 129.69 Million USD | 15.81% |
2019 Q2 | 116.03 Million USD | -10.54% |
2019 Q3 | 282.43 Million USD | 143.41% |
2018 Q4 | 111.98 Million USD | -5.21% |
2018 FY | 111.98 Million USD | 531.88% |
2018 Q1 | 140.67 Million USD | 693.77% |
2018 Q2 | 118.58 Million USD | -15.71% |
2018 Q3 | 118.14 Million USD | -0.37% |
2017 Q3 | 20.47 Million USD | -43.1% |
2017 Q2 | 35.98 Million USD | -21.68% |
2017 Q1 | 45.94 Million USD | 64.59% |
2017 FY | 17.72 Million USD | -36.51% |
2017 Q4 | 17.72 Million USD | -13.45% |
2016 FY | 27.91 Million USD | -14.38% |
2016 Q4 | 27.91 Million USD | 0.0% |
2016 Q1 | 29.1 Million USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | 32.6 Million USD | 117.48% |
2014 FY | 14.99 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Theratechnologies Inc. | 58.96 Million USD | -694.163% |
Harrow Health, Inc. | 190.5 Million USD | -145.825% |
Dynavax Technologies Corporation | 256.91 Million USD | -82.28% |
Biofrontera Inc. | 5.39 Million USD | -8573.866% |
Cronos Group Inc. | 2.53 Million USD | -18337.537% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -76923.355% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 34.552% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -1189.271% |
RedHill Biopharma Ltd. | 1.17 Million USD | -39823.24% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -2441.186% |
Radius Health, Inc. | 365.31 Million USD | -28.192% |
Universe Pharmaceuticals INC | 5.48 Million USD | -8441.829% |
DURECT Corporation | 20.74 Million USD | -2157.312% |
ProPhase Labs, Inc. | 21.38 Million USD | -2090.374% |
Safety Shot Inc | 1.54 Million USD | -30133.045% |
Phibro Animal Health Corporation | 525.45 Million USD | 10.878% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -17588.761% |
Alvotech | 1.07 Billion USD | 56.456% |
Assertio Holdings, Inc. | 40.91 Million USD | -1044.657% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -1027.705% |
Rockwell Medical, Inc. | 13.43 Million USD | -3384.649% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -71102.439% |
Procaps Group S.A. | 285.93 Million USD | -63.779% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -2664.801% |
SCYNEXIS, Inc. | 15.08 Million USD | -3005.451% |
Aytu BioPharma, Inc. | 15.12 Million USD | -2995.393% |
Viatris Inc. | 18.12 Billion USD | 97.416% |
OptiNose, Inc. | 131.74 Million USD | -255.45% |
SIGA Technologies, Inc. | 1.46 Million USD | -31887.645% |
Tilray Brands, Inc. | 387.31 Million USD | -20.909% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -71102.439% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | -9.314% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Alimera Sciences, Inc. | 67.39 Million USD | -594.82% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | 30.548% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -42954.572% |
Organogenesis Holdings Inc. | 119.35 Million USD | -292.374% |
Journey Medical Corporation | 17.73 Million USD | -2541.297% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -5558.151% |
Alpha Teknova, Inc. | 30.45 Million USD | -1437.534% |
Clever Leaves Holdings Inc. | 2.08 Million USD | -22339.003% |
Lifecore Biomedical, Inc. | 130.36 Million USD | -259.237% |
PainReform Ltd. | 86 Thousand USD | -544437.209% |
Cosmos Health Inc. | 12.42 Million USD | -3669.348% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -1223.485% |
TherapeuticsMD, Inc. | 8 Million USD | -5750.119% |
Embecta Corp. | 1.63 Billion USD | 71.419% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -782922.054% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 586.04 Million USD | 20.091% |
Incannex Healthcare Limited | 373 Thousand USD | -125450.134% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -45229.126% |
Shineco, Inc. | 29.65 Million USD | -1479.09% |
Procaps Group, S.A. | 285.93 Million USD | -63.779% |
ANI Pharmaceuticals, Inc. | 315.32 Million USD | -48.513% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | -373.884% |
Lantheus Holdings, Inc. | 616.94 Million USD | 24.094% |
Alvotech | 1.07 Billion USD | 56.456% |
Hempacco Co., Inc. | 13.72 Million USD | -3312.159% |
Eagle Pharmaceuticals, Inc. | 62.46 Million USD | -649.691% |
Bright Green Corporation | 1.85 Million USD | -25189.248% |
Esperion Therapeutics, Inc. | 540.94 Million USD | 13.429% |
Kamada Ltd. | 8.74 Million USD | -5252.643% |
Indivior PLC | 281.6 Million USD | -66.299% |
Evoke Pharma, Inc. | 5 Million USD | -9266.04% |
Flora Growth Corp. | 3.67 Million USD | -12653.322% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -45229.126% |
Evolus, Inc. | 126.54 Million USD | -270.065% |
HUTCHMED (China) Limited | 86.13 Million USD | -443.709% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 24.909% |
Akanda Corp. | 3.99 Million USD | -11611.09% |